IgA nephropathy with minimal change disease
- PMID: 24721885
- PMCID: PMC4046738
- DOI: 10.2215/CJN.11951113
IgA nephropathy with minimal change disease
Abstract
Background and objectives: Patients with IgA nephropathy typically present with hematuria and subnephrotic proteinuria. Nephrotic syndrome is uncommon in IgA nephropathy, and when present, it is usually associated with severe histologic features, such as endocapillary proliferation, segmental sclerosis, and crescent formation. Rarely, patients with IgA nephropathy present with nephrotic syndrome and only mild mesangial disease. This study sought to better characterize these patients.
Design, setting, participants, & measurements: A retrospective review of cases of IgA nephropathy diagnosed from 2004 to 2011 identified patients with nephrotic range proteinuria and histologically mild IgA nephropathy. Specifically, using the Oxford Classification of IgA Nephropathy, we identified cases that lacked endocapillary proliferation or segmental sclerosis.
Results: The cohort consisted of 17 patients, including 10 men and 15 adults. The median serum creatinine was 0.9 mg/dl (range=0.7-3.1), median 24-hour urine protein was 8.0 g/d (3.0-18.0 g), and 14 patients were fully nephrotic, whereas the remaining 3 patients fulfilled two of three criteria for nephrotic syndrome. Biopsies revealed IgA-dominant or codominant deposits accompanied by mesangial proliferation in 14 patients (82.4%). Electron microscopy showed mesangial deposits and extensive foot process effacement (median=90%). Initial treatment consisted of corticosteroids, although many patients required additional agents to maintain remission status. Over a median follow-up of 20 months (2.2-82 months), 14 patients experienced a complete response, and 3 patients showed a partial response, with a median response time of 2 months (0.5-27 months). At least one relapse of nephrotic syndrome occurred in nine patients (53%). All patients exhibited stable or improved renal function over the follow-up period.
Conclusions: The findings in this cohort and previous studies suggest that rare cases of mild IgA nephropathy with nephrotic range proteinuria exhibit a clinical presentation, biopsy findings, treatment response, and outcome more typical of IgA nephropathy with superimposed minimal change disease. This study favors the view that such cases represent a dual glomerulopathy.
Keywords: IgA; nephrotic syndrome; renal biopsy; renal pathology.
Copyright © 2014 by the American Society of Nephrology.
Figures

Similar articles
-
Clinical characteristics of concomitant nephrotic IgA nephropathy and minimal change disease in children.Nephron. 2015;130(1):21-8. doi: 10.1159/000382035. Epub 2015 Apr 22. Nephron. 2015. PMID: 25924689
-
Comparison between patients with IgA nephropathy with minimal change disease and patients with minimal change disease.Clin Nephrol. 2016 May;85(5):273-81. doi: 10.5414/CN108727. Clin Nephrol. 2016. PMID: 26951969
-
ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.Am J Kidney Dis. 2000 Oct;36(4):709-18. doi: 10.1053/ajkd.2000.17615. Am J Kidney Dis. 2000. PMID: 11007672
-
[Minimal-change disease with mesangial IgA deposits associated with Sjogren syndrome].Nefrologia. 2002;22(4):386-9. Nefrologia. 2002. PMID: 12369132 Review. Spanish.
-
Mesangial immunoglobulin A deposits in minimal change nephrotic syndrome: a report of an older patient and review of the literature.Am J Nephrol. 1990;10(1):31-6. doi: 10.1159/000168050. Am J Nephrol. 1990. PMID: 2111636 Review.
Cited by
-
The difference between patients with nephrotic syndrome and nephrotic-range proteinuria in IgA nephropathy: a propensity score matched cohort study.BMC Nephrol. 2022 Apr 29;23(1):163. doi: 10.1186/s12882-022-02799-3. BMC Nephrol. 2022. PMID: 35488221 Free PMC article.
-
A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.BMC Immunol. 2018 Jun 20;19(1):18. doi: 10.1186/s12865-018-0254-z. BMC Immunol. 2018. PMID: 29925312 Free PMC article.
-
The protective effect and mechanism of rapamycin in the rat model of IgA nephropathy.Ren Fail. 2019 Nov;41(1):334-339. doi: 10.1080/0886022X.2019.1577257. Ren Fail. 2019. PMID: 31057050 Free PMC article.
-
Pitfalls in the Pathological Diagnosis of Glomerular Diseases: Why Stop at One?Glomerular Dis. 2025 Apr 29;5(1):250-260. doi: 10.1159/000546083. eCollection 2025 Jan-Dec. Glomerular Dis. 2025. PMID: 40520345 Free PMC article.
-
Clinicopathological analysis of IgA nephropathy combined with other glomerular diseases.Medicine (Baltimore). 2019 Oct;98(41):e17388. doi: 10.1097/MD.0000000000017388. Medicine (Baltimore). 2019. PMID: 31593089 Free PMC article.
References
-
- Tumlin JA, Madaio MP, Hennigar R: Idiopathic IgA nephropathy: Pathogenesis, histopathology, and therapeutic options. Clin J Am Soc Nephrol 2: 1054–1061, 2007 - PubMed
-
- D’Amico G: Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 24: 179–196, 2004 - PubMed
-
- Barratt J, Feehally J: Treatment of IgA nephropathy. Kidney Int 69: 1934–1938, 2006 - PubMed
-
- Cheng IK, Chan KW, Chan MK: Mesangial IgA nephropathy with steroid-responsive nephrotic syndrome: Disappearance of mesangial IgA deposits following steroid-induced remission. Am J Kidney Dis 14: 361–364, 1989 - PubMed
-
- Clive DM, Galvanek EG, Silva FG: Mesangial immunoglobulin A deposits in minimal change nephrotic syndrome: A report of an older patient and review of the literature. Am J Nephrol 10: 31–36, 1990 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous